Price $93.01 |
Market Cap
5.06B
|
Sector Health Care |
Div. Growth
4.80%
|
|
P/E
23.1
|
P/B
4.04
|
P/S
1.67
|
Dividend %
0.30%
|
|
P/CF
96.1
|
P/FCF
29.6
|
Op. Cash Flow
272.5K
|
FCF
3.0
|
|
Op. Margin
9.80%
|
Net Margin
7.40%
|
ROE
19.50%
|
ROI
16.60%
|
|
ROA
7.00%
|
EPS Growth
14.50%
|
Current Ratio
1.3
|
Debt/Equity
12.00%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| China Pharma Holdings Inc (CPHI) | $0.40 | - | - | 3.6M | Strong Buy |
| Malachite Innovations Inc (MLCT) | $0.17 | - | - | 11.7M | Strong Buy |
| Cytosorbents Corp (CTSO) | $3.43 | - | - | 136.1M | Strong Buy |
| Teva Pharmaceutical Industries (TEVA) | $8.82 | - | - | 11.23B | Strong Buy |
| Mallinckrodt PLC (MNK) | $7.38 | - | - | 114.9M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
